The hardware and bandwidth for this mirror is donated by METANET, the Webhosting and Full Service-Cloud Provider.
If you wish to report a bug, or if you are interested in having us mirror your free-software or open-source project, please feel free to contact us at mirror[@]metanet.ch.

GFDrmst: Multiple RMST-Based Tests in General Factorial Designs

We implemented multiple tests based on the restricted mean survival time (RMST) for general factorial designs as described in Munko et al. (2024) <doi:10.1002/sim.10017>. Therefore, an asymptotic test, a groupwise bootstrap test, and a permutation test are incorporated with a Wald-type test statistic. The asymptotic and groupwise bootstrap test take the asymptotic exact dependence structure of the test statistics into account to gain more power. Furthermore, confidence intervals for RMST contrasts can be calculated and plotted and a stepwise extension that can improve the power of the multiple tests is available.

Version: 0.1.1
Imports: GFDmcv, lpSolve, shinyWidgets, shinyMatrix, shiny (≥ 1.5.0), tippy (≥ 0.1.0), mvtnorm, MASS (≥ 7.3-53), plyr (≥ 1.8.6), shinyjs (≥ 2.0.0), shinythemes (≥ 1.1.2)
Suggests: condSURV
Published: 2024-08-19
DOI: 10.32614/CRAN.package.GFDrmst
Author: Marc Ditzhaus [aut], Dennis Dobler [aut], Marc Kindop [aut], Merle Munko [aut, cre]
Maintainer: Merle Munko <merle.munko at ovgu.de>
License: GPL (≥ 3)
NeedsCompilation: no
CRAN checks: GFDrmst results

Documentation:

Reference manual: GFDrmst.pdf

Downloads:

Package source: GFDrmst_0.1.1.tar.gz
Windows binaries: r-devel: GFDrmst_0.1.1.zip, r-release: GFDrmst_0.1.1.zip, r-oldrel: GFDrmst_0.1.1.zip
macOS binaries: r-release (arm64): GFDrmst_0.1.1.tgz, r-oldrel (arm64): GFDrmst_0.1.1.tgz, r-release (x86_64): GFDrmst_0.1.1.tgz, r-oldrel (x86_64): GFDrmst_0.1.1.tgz
Old sources: GFDrmst archive

Reverse dependencies:

Reverse imports: GFDrmtl

Linking:

Please use the canonical form https://CRAN.R-project.org/package=GFDrmst to link to this page.

These binaries (installable software) and packages are in development.
They may not be fully stable and should be used with caution. We make no claims about them.